Back Home Search

Non-Production - Recurrent

  • Platinum Resistant0
  • Platinum Sensitive0
  • Protocols

  • EAY191N4

    OPEN TO ACCRUAL

    Ph2 Randomized Selumetinib, Olaparib or Selumetinib in Patients w/Ovarian and Endometrial Cancer